About EurobioGenBio
Founded in 1994, GenBio is a fully integrated diagnostics company specializing in infectious disease and autoimmune testing. The company develops, manufactures, and markets a broad portfolio of serology products in compliance with U.S. FDA and ISO 13485 standards.
GenBio is part of the Eurobio Scientific Group, a leading European provider of specialty in vitro diagnostics with expertise spanning discovery, development, production, and commercialization of diagnostic solutions. As a member of the Group, GenBio benefits from expanded scientific capabilities, a broader proprietary product portfolio, and an established international commercial infrastructure, strengthening its ability to serve global markets.
GenBio combines strong commercialization capabilities with extensive healthcare industry expertise, resulting in successful product lines marketed under both GenBio and international partner brands. The company is committed to delivering high-quality, cost-effective solutions that meet global regulatory requirements and the evolving needs of modern laboratories.
In addition, GenBio supports the distribution of GenDx products—part of the Eurobio Scientific Group—extending its offering into advanced molecular diagnostics, particularly in transplantation and HLA typing. This further enhances GenBio’s position as a comprehensive diagnostics partner.
GenBio’s strategy emphasizes rapid commercialization, effective global market development, and timely delivery of innovative products and technologies, including the development of customized solutions tailored to specific regional market needs.